-
Astellas to Acquire Ogeda SA
contractpharma
April 05, 2017
Astellas Pharma Inc. has entered into a definitive agreement to acquire Ogeda SA.
-
Astellas Names President of Astellas US Technologies
contractpharma
April 05, 2017
John DeMay will be responsible for collaboration and cooperation across pharmaceutical technology divisions
-
Astellas, Affinivax team up on 'next-gen' pneumococcal vaccine to target Pfizer’s Prevnar
fiercepharma
March 01, 2017
Astellas just forged a licensing deal with Affinivax to develop a pneumococcal vaccine. Their target? Pfizer’s Prevnar 13—the world’s bestselling vaccine.
-
Astellas and Lupin’s subsidiary Kyowa enter into an agreement
expressbpd
February 28, 2017
Kyowa to exclusively market Quetiapine Fumarate extended-release tablets in Japan
-
Astellas announces participation in Access Accelerated
pharmaasia
February 16, 2017
Astellas Pharma Inc. has announced its participation in Access Accelerated, a global, multi-stakeholder initiative to advance access to non-communicable disease (NCD) prevention, diagnostics and treatment in low-income and lower-middle income countries. T
-
Astellas Names Friedman General Counsel for Worldwide Legal Organization and Executive Committee Mem
Astellas has announced the promotion of Linda Frie
February 10, 2017
Astellas has announced the promotion of Linda Friedman as executive vice president, general counsel, with responsibility for the company's Legal organization worldwide,
-
Astellas Names Linda Friedman General Counsel for Worldwide Legal Organization and Executive Committ
firstwordpharma
February 09, 2017
Astellas Americas Names Catherine Levitt Regional General Counsel for the Americas
-
With Flublok at a standstill in Japan, Astellas ditches cell-culture vax collab
fiercepharma
January 19, 2017
After Japanese regulators turned away the partners’ submission for a new cell-culture flu vaccine, Astellas has pulled the plug on a collaboration with UMN Pharma.